The effect of repetitive transcranial magnetic stimulation on motor performance, fatigue and quality of life in amyotrophic lateral sclerosis

Journal of the Neurological Sciences

Volumn 270, Issue 1-2, 2008, Pages 18-22

  Zanette, Giampietro ^a,b   Forgione, Antonio ^b   Manganotti, Paolo ^a   Fiaschi, Antonio ^a   Tamburin, Stefano ^a,b  

^a UNIVERSITY OF VERONA   (Italy)

^b PEDERZOLI HOSPITAL   (Italy)

Author keywords

Amyotrophic lateral sclerosis (ALS); Fatigue; Muscle strength; Quality of life (QoL); Therapy; Transcranial magnetic stimulation (TMS)

Indexed keywords

ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYNAMOMETRY; FATIGUE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MALE; MOTOR PERFORMANCE; MUSCLE FUNCTION; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; TRANSCRANIAL MAGNETIC STIMULATION; VOLUNTARY MOVEMENT;

AGED; AMYOTROPHIC LATERAL SCLEROSIS; ANALYSIS OF VARIANCE; FATIGUE; FEMALE; HUMANS; ISOTONIC CONTRACTION; MALE; MIDDLE AGED; MOTOR ACTIVITY; QUALITY OF LIFE; TIME FACTORS; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

EID: 44649161876     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2008.01.011     Document Type: Article

References (28)

1. Rowland L.P., and Shneider N.A. Amyotrophic lateral sclerosis. N Engl J Med 344 (2001) 1688-1700
2. Zanette G., Tamburin S., Manganotti P., Refatti N., Forgione A., and Rizzuto N. Different mechanisms contribute to motor cortex hyperexcitability in amyotrophic lateral sclerosis. Clin Neurophysiol 113 (2002) 1688-1697
3. Miller R.G., Mitchell J.D., Lyon M., and Moore D.H. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND). Cochrane Database Syst Rev CD001447 (2002)
4. Andersen P.M., Borasio G.D., Dengler R., Hardiman O., Kollewe K., Leigh P.N., et al. EFNS task force on management of amyotrophic lateral sclerosis: guidelines for diagnosing and clinical care of patients and relatives. An evidence-based review with good practice points. Eur J Neurol 12 (2005) 921-938
5. Wassermann E.M., and Lisanby S.H. Therapeutic application of repetitive transcranial magnetic stimulation: a review. Clin Neurophysiol 112 (2001) 1367-1377
6. Chen R., Classen J., Gerloff C., Celnik P., Wassermann E.M., Hallett M., et al. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 48 (1997) 1398-1403
7. Ziemann U., and Eisen A. TMS for ALS: why and why not. Clin Neurophysiol 115 (2004) 1237-1238
8. Di Lazzaro V., Oliviero A., Berardelli A., Mazzone P., Insola A., Pilato F., et al. Direct demonstration of the effects of repetitive transcranial magnetic stimulation on the excitability of the human motor cortex. Exp Brain Res 144 (2002) 549-553
9. Fujiki M., Kobayashi H., Abe T., and Kamida T. Repetitive transcranial magnetic stimulation for protection against delayed neuronal death induced by transient ischemia. J Neurosurg 99 (2003) 1063-1069
10. Angelucci F., Oliviero A., Pilato F., Saturno E., Dileone M., Versace V., et al. Transcranial magnetic stimulation and BDNF plasma levels in amyotrophic lateral sclerosis. Neuroreport 15 (2004) 717-720
11. Di Lazzaro V., Olivieri A., Saturno E., Pilato F., Dileone M., Sabatelli M., et al. Motor cortex stimulation for amyotrophic lateral sclerosis. Time for a therapeutic trial?. Clin Neurophysiol 115 (2004) 1479-1485
12. Di Lazzaro V., Dileone M., Pilato F., Profice P., Ranieri F., Musumeci G., et al. Repetitive transcranial magnetic stimulation for ALS. A preliminary controlled study. Neurosci Lett 408 (2006) 135-140
13. Brooks B.R., Miller R.G., Swash M., and Munsat T.L. World Federation of Neurology Research Group on Motor Neuron Diseases. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Mot Neuron Disord 1 (2000) 293-299
14. Wassermann E.M. Risk and safety of repetitive transcranial magnetic stimulation: report and suggested guidelines from the International Workshop on the Safety of Repetitive Transcranial Magnetic Stimulation, June 5-7, 1996. Electroencephalogr Clin Neurophysiol 108 (1998) 1-16
15. Kaufmann P., Levy G., Thompson J.L.P., DelBene M.L., Battista V., Gordon P.H., et al. The ALSFRSr predicts survival time in an ALS clinic population. Neurology 64 (2005) 38-43
16. Krupp L.B., La Rocca N.G., Muir-Nash J., and Steinberg A.D. The fatigue severity scale. Arch Neurol 46 (1989) 1121-1123
17. Ware J.E., and Sherbourne C.D. The MOS 36-item short-form survey (SF-36). Conceptual framework and item selection. Med Care 30 (1992) 473-483
18. Neudert C., Wasner M., and Borasio G.D. Patients' assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis. J Neurol Sci 191 (2001) 103-109
19. Sufit R., Clough J.A., Schram M., Conrad J., Erickson L., and Brooks B.R. Isokinetic assessment in ALS. Neurol Clin 5 (1987) 197-212
20. Eng J.J., Kim C.M., and MacIntyre D.L. Reliability of lower extremity strength measures in persons with chronic stroke. Arch Phys Med Rehabil 83 (2002) 322-328
21. Jenkinson C., Hobart J., Chandola T., Fitzpatrick R., Peto V., Swash M., et al. Use of the short form health survey (SF-36) in patients with amyotrophic lateral sclerosis: tests of data quality, score reliability, response rate and scaling assumptions. J Neurol 249 (2002) 178-183
22. Lo Coco G., Lo Coco D., Cicero V., Oliveri A., Lo Verso G., Piccoli F., et al. Individual and health-related quality of life assessment in amyotrophic lateral sclerosis patients and their caregivers. J Neurol Sci 238 (2005) 11-17
23. Lou J.S., Reeves A., Benice T., and Sexton G. Fatigue and depression are associated with poor quality of life in ALS. Neurology 60 (2003) 122-123
24. Sanjak M., Brinkmann J., Belden D.S., Roelke K., Waclawik A., Neville H.E., et al. Quantitative assessment of motor fatigue in amyotrophic lateral sclerosis. J Neurol Sci 191 (2001) 55-59
25. Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp Neurol 185 (2004) 232-240
26. Drory V.E., Goltsman E., Reznik J.G., Mosek A., and Korczyn A.D. The value of muscle exercise in patients with amyotrophic lateral sclerosis. J Neurol Sci 191 (2001) 133-137
27. Helmich R.C., Siebner H.R., Bakker M., Münchau A., and Bloem B.R. Repetitive transcranial magnetic stimulation to improve mood and motor function in Parkinson's disease. J Neurol Sci 248 (2006) 84-96
28. Loo C.K., and Mitchell P.B. A review of the efficacy of transcranial magnetic stimulation (TMS) treatment for depression, and current and future strategies to optimize efficacy. J Affect Disord 88 (2005) 255-267